サマリー

COVID-19の大流行により、Injectable Skin Fillersの世界市場規模は2022年に5992.68万米ドルと推定され、2028年には12190.13万米ドルに再調整され、予測期間2022-2028年にはCAGR 12.56% で予測されています。この健康危機による経済変化を十分に考慮すると、2021年にInjectable Skin Fillers世界市場の73.79%を占めるヒアルロン酸は、2028年までに9億1,502万米ドルの価値を持ち、2022年から2028年までのCAGR12.86%で成長すると予測されます。

注射用スキンフィラーの世界的な主要メーカーには、Allergan、Galderma、LG Life Sciences、Merz、Medytox、HUGEL、Croma-Pharma GmbH、Beijing IMEIK、Bloomage BioTechnologyなどが挙げられます。収益面では、2021年のInjectable Skin Fillersの市場シェアは世界5大企業が71.84％を占めている。
本レポートは、世界レベル、地域レベル、企業レベルでのInjectable Skin Fillersの数量と価値に焦点を当てている。グローバルな視点から、過去のデータと将来の見通しを分析し、Injectable Skin Fillersの全体的な市場規模を表現しています。地域的には、このレポートはいくつかの主要な地域に焦点を当てています。北米、欧州、APAC、南米、中東、アフリカです。

注射用スキンフィラーの世界市場。セグメント分析
この調査レポートには、地域（国）別、企業別、タイプ別、用途別の具体的なセグメントが含まれています。この調査では、2017年から2028年までの歴史的期間および予測期間における売上高と収益に関する情報を提供しています。セグメントを理解することは、市場成長を助ける様々な要因の重要性を特定するのに役立ちます。
世界の注射用スキンフィラー市場セグメント分析
この調査レポートは、地域（国）別、メーカー別、タイプ別、用途別の具体的なセグメントを含んでいます。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。 アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。

企業別
アッヴィ
ガルデルマ
LGライフサイエンス
メルツ
北京IMEIK
テオキサン
ヒューゲル
ブルメージバイオ
シンクレア
エルラヴィー（ヒューメディックス）
クロマファーマ
Cleviel（ファーマ リサーチ プロダクツ）
メディトックス
ハオハイバイオロジカル
プロレニウム
スネバメディカル
Q.O.Fill(JWファーマシューティカル)
サイビジョンバイオテック
マテックス・ラボ
CGバイオ
ケアジェン
ボーハス・バイオテック
ジェノス
ジンジャ・メディカル

種類別セグメント
ヒアルロン酸
コラーゲン
CaHA
その他

用途別セグメント
専門医・皮膚科クリニック
病院・クリニック
その他

地域別消費量
北アメリカ
米国
カナダ
メキシコ
アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
その他の欧州
南米
ブラジル
南米のその他
中近東・アフリカ
中近東
アフリカ

ページTOPに戻る

目次

1 INJECTABLE SKIN FILLERS MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF INJECTABLE SKIN FILLERS 1
1.2 INJECTABLE SKIN FILLERS SEGMENT BY TYPE 1
1.2.1 GLOBAL INJECTABLE SKIN FILLERS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 HYALURONIC ACID 3
1.2.3 COLLAGEN 4
1.2.4 CAHA 4
1.2.5 OTHERS 5
1.3 INJECTABLE SKIN FILLERS SEGMENT BY APPLICATION 5
1.3.1 GLOBAL INJECTABLE SKIN FILLERS SALES COMPARISON BY APPLICATION (2022-2028) 6
1.3.2 SPECIALIST AND DERMATOLOGY CLINIC 7
1.3.3 HOSPITALS AND CLINICS 8
1.3.4 OTHERS 8
1.4 GLOBAL INJECTABLE SKIN FILLERS MARKET SIZE ESTIMATES AND FORECASTS 8
1.4.1 GLOBAL INJECTABLE SKIN FILLERS REVENUE 2017-2028 8
1.4.2 GLOBAL INJECTABLE SKIN FILLERS SALES 2017-2028 9
1.4.3 INJECTABLE SKIN FILLERS MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 10
2 INJECTABLE SKIN FILLERS MARKET COMPETITION BY MANUFACTURERS 11
2.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 11
2.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 14
2.3 GLOBAL INJECTABLE SKIN FILLERS AVERAGE PRICE BY MANUFACTURERS (2017-2022) 18
2.4 MANUFACTURERS INJECTABLE SKIN FILLERS MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE 19
2.5 INJECTABLE SKIN FILLERS MARKET COMPETITIVE SITUATION AND TRENDS 20
2.5.1 INJECTABLE SKIN FILLERS MARKET CONCENTRATION RATE 20
2.5.2 THE GLOBAL 5 AND 10 LARGEST INJECTABLE SKIN FILLERS PLAYERS MARKET SHARE BY REVENUE 21
2.5.3 GLOBAL INJECTABLE SKIN FILLERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 22
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 23
3 INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO BY REGION 24
3.1 GLOBAL INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 24
3.2 GLOBAL INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 24
3.3 NORTH AMERICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY 25
3.3.1 NORTH AMERICA INJECTABLE SKIN FILLERS SALES BY COUNTRY 25
3.3.2 NORTH AMERICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY 26
3.3.3 UNITED STATES 27
3.3.4 CANADA 27
3.3.5 MEXICO 28
3.4 EUROPE INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY 28
3.4.1 EUROPE INJECTABLE SKIN FILLERS SALES BY COUNTRY 28
3.4.2 EUROPE INJECTABLE SKIN FILLERS REVENUE BY COUNTRY 29
3.4.3 GERMANY 30
3.4.4 FRANCE 30
3.4.5 U.K. 31
3.4.6 ITALY 31
3.4.7 RUSSIA 32
3.5 ASIA PACIFIC INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY REGION 32
3.5.1 ASIA PACIFIC INJECTABLE SKIN FILLERS SALES BY REGION 32
3.5.2 ASIA PACIFIC INJECTABLE SKIN FILLERS REVENUE BY REGION 33
3.5.3 CHINA 34
3.5.4 JAPAN 34
3.5.5 SOUTH KOREA 35
3.5.6 INDIA 35
3.5.7 AUSTRALIA 36
3.5.8 SOUTHEAST ASIA 36
3.6 SOUTH AMERICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY 37
3.6.1 SOUTH AMERICA INJECTABLE SKIN FILLERS SALES BY COUNTRY 37
3.6.2 SOUTH AMERICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY 37
3.6.3 BRAZIL 38
3.7 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY 38
3.7.1 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS SALES BY COUNTRY 38
3.7.2 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY 39
3.7.3 MIDDLE EAST 40
3.7.4 AFRICA 40
4 INJECTABLE SKIN FILLERS HISTORIC MARKET ANALYSIS BY TYPE 41
4.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY TYPE (2017-2022) 41
4.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY TYPE (2017-2022) 42
4.3 GLOBAL INJECTABLE SKIN FILLERS PRICE BY TYPE (2017-2022) 42
5 INJECTABLE SKIN FILLERS HISTORIC MARKET ANALYSIS BY APPLICATION 43
5.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY APPLICATION (2017-2022) 43
5.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY APPLICATION (2017-2022) 43
5.3 GLOBAL INJECTABLE SKIN FILLERS PRICE BY APPLICATION (2017-2022) 44
6 KEY COMPANIES PROFILED 45
6.1 ABBVIE 45
6.1.1 ABBVIE CORPORATION INFORMATION 45
6.1.2 ABBVIE INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 46
6.1.3 ABBVIE INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 46
6.1.4 ABBVIE RECENT DEVELOPMENTS/UPDATES 47
6.2 GALDERMA 47
6.2.1 GALDERMA CORPORATION INFORMATION 47
6.2.2 GALDERMA INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 48
6.2.3 GALDERMA INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 49
6.2.4 GALDERMA RECENT DEVELOPMENTS/UPDATES 49
6.3 LG LIFE SCIENCES 49
6.3.1 LG LIFE SCIENCES CORPORATION INFORMATION 49
6.3.2 LG LIFE SCIENCES INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 50
6.3.3 LG LIFE SCIENCES INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 51
6.3.4 LG LIFE SCIENCES RECENT DEVELOPMENTS/UPDATES 51
6.4 MERZ 52
6.4.1 MERZ CORPORATION INFORMATION 52
6.4.2 MERZ INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 53
6.4.3 MERZ INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 53
6.4.4 MERZ RECENT DEVELOPMENTS/UPDATES 53
6.5 MEDYTOX 54
6.5.1 MEDYTOX CORPORATION INFORMATION 54
6.5.2 MEDYTOX INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 55
6.5.3 MEDYTOX INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 55
6.5.4 MEDYTOX RECENT DEVELOPMENTS/UPDATES 56
6.6 HUGEL 56
6.6.1 HUGEL CORPORATION INFORMATION 56
6.6.2 HUGEL INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 57
6.6.3 HUGEL INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 57
6.6.4 HUGEL RECENT DEVELOPMENTS/UPDATES 57
6.7 CROMA-PHARMA GMBH 58
6.7.1 CROMA-PHARMA GMBH CORPORATION INFORMATION 58
6.7.2 CROMA-PHARMA GMBH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 58
6.7.3 CROMA-PHARMA GMBH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 59
6.7.4 CROMA-PHARMA GMBH RECENT DEVELOPMENTS/UPDATES 59
6.8 BEIJING IMEIK 59
6.8.1 BEIJING IMEIK CORPORATION INFORMATION 59
6.8.2 BEIJING IMEIK INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 61
6.8.3 BEIJING IMEIK INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 61
6.8.4 BEIJING IMEIK RECENT DEVELOPMENTS/UPDATES 61
6.9 BLOOMAGE BIOTECHNOLOGY 62
6.9.1 BLOOMAGE BIOTECHNOLOGY CORPORATION INFORMATION 62
6.9.2 BLOOMAGE BIOTECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 62
6.9.3 BLOOMAGE BIOTECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 63
6.9.4 BLOOMAGE BIOTECHNOLOGY RECENT DEVELOPMENTS/UPDATES 63
6.10 ELRAVIE (HUMEDIX) 63
6.10.1 ELRAVIE (HUMEDIX) CORPORATION INFORMATION 63
6.10.2 ELRAVIE (HUMEDIX) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 64
6.10.3 ELRAVIE (HUMEDIX) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 65
6.10.4 ELRAVIE (HUMEDIX) RECENT DEVELOPMENTS/UPDATES 65
6.11 CLEVIEL (PHARMA RESEARCH PRODUCTS) 65
6.11.1 CLEVIEL (PHARMA RESEARCH PRODUCTS) CORPORATION INFORMATION 65
6.11.2 CLEVIEL (PHARMA RESEARCH PRODUCTS) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 66
6.11.3 CLEVIEL (PHARMA RESEARCH PRODUCTS) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 66
6.11.4 CLEVIEL (PHARMA RESEARCH PRODUCTS) RECENT DEVELOPMENTS/UPDATES 67
6.12 HAOHAI BIOLOGICAL TECHNOLOGY 67
6.12.1 HAOHAI BIOLOGICAL TECHNOLOGY CORPORATION INFORMATION 67
6.12.2 HAOHAI BIOLOGICAL TECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 68
6.12.3 HAOHAI BIOLOGICAL TECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 69
6.12.4 HAOHAI BIOLOGICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES 69
6.13 Q.O.FILL (JW PHARMACEUTICAL) 70
6.13.1 Q.O.FILL (JW PHARMACEUTICAL) CORPORATION INFORMATION 70
6.13.2 Q.O.FILL (JW PHARMACEUTICAL) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 70
6.13.3 Q.O.FILL (JW PHARMACEUTICAL) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 71
6.13.4 Q.O.FILL (JW PHARMACEUTICAL) RECENT DEVELOPMENTS/UPDATES 71
6.14 TEOXANE 72
6.14.1 TEOXANE CORPORATION INFORMATION 72
6.14.2 TEOXANE INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 73
6.14.3 TEOXANE INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 73
6.14.4 TEOXANE RECENT DEVELOPMENTS/UPDATES 74
6.15 SINCLAIR 74
6.15.1 SINCLAIR CORPORATION INFORMATION 74
6.15.2 SINCLAIR INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 75
6.15.3 SINCLAIR INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 75
6.15.4 SINCLAIR RECENT DEVELOPMENTS/UPDATES 76
6.16 SUNEVA MEDICAL 76
6.16.1 SUNEVA MEDICAL CORPORATION INFORMATION 76
6.16.2 SUNEVA MEDICAL INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 77
6.16.3 SUNEVA MEDICAL INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 77
6.16.4 SUNEVA MEDICAL RECENT DEVELOPMENTS/UPDATES 78
6.17 CG BIO 78
6.17.1 CG BIO CORPORATION INFORMATION 78
6.17.2 CG BIO INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 79
6.17.3 CG BIO INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 79
6.17.4 CG BIO RECENT DEVELOPMENTS/UPDATES 80
6.18 SCIVISION BIOTECH 80
6.18.1 SCIVISION BIOTECH CORPORATION INFORMATION 80
6.18.2 SCIVISION BIOTECH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 81
6.18.3 SCIVISION BIOTECH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 81
6.18.4 SCIVISION BIOTECH RECENT DEVELOPMENTS/UPDATES 82
6.19 PROLLENIUM 82
6.19.1 PROLLENIUM CORPORATION INFORMATION 82
6.19.2 PROLLENIUM INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 83
6.19.3 PROLLENIUM INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 83
6.20 MATEX-LAB 84
6.20.1 MATEX-LAB CORPORATION INFORMATION 84
6.20.2 MATEX-LAB INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 85
6.20.3 MATEX-LAB INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 85
6.20.4 MATEX-LAB RECENT DEVELOPMENTS/UPDATES 86
6.21 JINGJIA MEDICAL TECHNOLOGY 86
6.21.1 JINGJIA MEDICAL TECHNOLOGY CORPORATION INFORMATION 86
6.21.2 JINGJIA MEDICAL TECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 87
6.21.3 JINGJIA MEDICAL TECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 87
6.21.4 JINGJIA MEDICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES 88
6.22 GENOSS 88
6.22.1 GENOSS CORPORATION INFORMATION 88
6.22.2 GENOSS INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 89
6.22.3 GENOSS INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 90
6.22.4 GENOSS RECENT DEVELOPMENTS/UPDATES 90
6.23 BOHUS BIOTECH 90
6.23.1 BOHUS BIOTECH CORPORATION INFORMATION 90
6.23.2 BOHUS BIOTECH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 91
6.23.3 BOHUS BIOTECH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 91
6.24 CAREGEN 92
6.24.1 CAREGEN CORPORATION INFORMATION 92
6.24.2 CAREGEN INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 93
6.24.3 CAREGEN INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO 93
7 INJECTABLE SKIN FILLERS MANUFACTURING COST ANALYSIS 94
7.1 INJECTABLE SKIN FILLERS KEY RAW MATERIALS ANALYSIS 94
7.1.1 KEY RAW MATERIALS 94
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 95
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 96
7.3 MANUFACTURING PROCESS ANALYSIS OF INJECTABLE SKIN FILLERS 96
7.4 INJECTABLE SKIN FILLERS INDUSTRIAL CHAIN ANALYSIS 97
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 98
8.1 MARKETING CHANNEL 98
8.2 INJECTABLE SKIN FILLERS DISTRIBUTORS LIST 98
8.3 INJECTABLE SKIN FILLERS CUSTOMERS 100
9 INJECTABLE SKIN FILLERS MARKET DYNAMICS 101
9.1 INJECTABLE SKIN FILLERS INDUSTRY TRENDS 101
9.2 INJECTABLE SKIN FILLERS MARKET DRIVERS 101
9.3 INJECTABLE SKIN FILLERS MARKET CHALLENGES AND RESTRAINTS 103
10 GLOBAL MARKET FORECAST 104
10.1 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY TYPE 104
10.1.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY TYPE (2023-2028) 104
10.1.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY TYPE (2023-2028) 104
10.2 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 105
10.2.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY APPLICATION (2023-2028) 105
10.2.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY APPLICATION (2023-2028) 106
10.3 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY REGION 106
10.3.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY REGION (2023-2028) 106
10.3.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY REGION (2023-2028) 107
11 RESEARCH FINDINGS AND CONCLUSION 108
12 METHODOLOGY AND DATA SOURCE 110
12.1 METHODOLOGY/RESEARCH APPROACH 110
12.1.1 RESEARCH PROGRAMS/DESIGN 110
12.1.2 MARKET SIZE ESTIMATION 111
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 112
12.2 DATA SOURCE 113
12.2.1 SECONDARY SOURCES 113
12.2.2 PRIMARY SOURCES 114
12.3 AUTHOR LIST 116
12.4 DISCLAIMER 116